Tilray Brands (TLRY) EBIT Growth (3y) (2022 - 2026)
Tilray Brands (TLRY) EBIT Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 513.31 Mn | 278.68 Mn | 90.52 Mn | 43.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 43.24% |
| Feb 28, 2026 | 72.04% |
| Nov 30, 2025 | 24.51% |
| Aug 31, 2025 | 28.03% |
| May 31, 2025 | -45.64% |
| Feb 28, 2025 | -247.69% |
| Nov 30, 2024 | 8.73% |
| Aug 31, 2024 | 19.22% |
| May 31, 2024 | 39.24% |
| Feb 29, 2024 | -50.57% |
| Nov 30, 2023 | -17.17% |
| Aug 31, 2023 | -59.46% |
| May 31, 2023 | -72.38% |
| May 31, 2022 | -416.71% |